| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epidermodysplasia Verruciformis | 7 | 2023 | 13 | 1.840 |
Why?
|
| Ichthyosis | 11 | 2022 | 29 | 1.810 |
Why?
|
| Skin Diseases | 5 | 2022 | 129 | 1.780 |
Why?
|
| Collagen Type VII | 4 | 2018 | 6 | 1.460 |
Why?
|
| Homozygote | 16 | 2024 | 547 | 1.450 |
Why?
|
| High-Throughput Nucleotide Sequencing | 11 | 2024 | 887 | 1.430 |
Why?
|
| Epidermolysis Bullosa Dystrophica | 3 | 2018 | 10 | 1.300 |
Why?
|
| Epidermolysis Bullosa | 8 | 2022 | 25 | 1.280 |
Why?
|
| Papillomavirus Infections | 5 | 2023 | 296 | 1.190 |
Why?
|
| Pseudoxanthoma Elasticum | 4 | 2022 | 4 | 1.180 |
Why?
|
| Consanguinity | 14 | 2024 | 116 | 1.150 |
Why?
|
| Mutation | 31 | 2024 | 5897 | 1.100 |
Why?
|
| Genetic Testing | 4 | 2024 | 1016 | 1.060 |
Why?
|
| Genetic Heterogeneity | 4 | 2022 | 127 | 0.930 |
Why?
|
| Hypotrichosis | 2 | 2019 | 8 | 0.800 |
Why?
|
| Pedigree | 22 | 2025 | 1610 | 0.790 |
Why?
|
| Skin Diseases, Vesiculobullous | 2 | 2018 | 3 | 0.740 |
Why?
|
| Mutation, Missense | 8 | 2021 | 879 | 0.730 |
Why?
|
| Skin | 11 | 2023 | 519 | 0.710 |
Why?
|
| Patched-1 Receptor | 1 | 2020 | 44 | 0.680 |
Why?
|
| Sequence Deletion | 2 | 2019 | 528 | 0.670 |
Why?
|
| Ichthyosis, Lamellar | 4 | 2022 | 8 | 0.660 |
Why?
|
| Whole Genome Sequencing | 3 | 2023 | 283 | 0.650 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2020 | 71 | 0.640 |
Why?
|
| Transcriptome | 2 | 2023 | 978 | 0.620 |
Why?
|
| Warts | 3 | 2023 | 14 | 0.600 |
Why?
|
| Cadherins | 1 | 2019 | 172 | 0.600 |
Why?
|
| Mosaicism | 1 | 2020 | 239 | 0.590 |
Why?
|
| Macular Degeneration | 1 | 2019 | 115 | 0.580 |
Why?
|
| Genetic Predisposition to Disease | 7 | 2024 | 3175 | 0.520 |
Why?
|
| Epidermolysis Bullosa Simplex | 3 | 2022 | 4 | 0.480 |
Why?
|
| Membrane Proteins | 6 | 2023 | 1538 | 0.460 |
Why?
|
| Iran | 10 | 2024 | 89 | 0.430 |
Why?
|
| Humans | 62 | 2025 | 125025 | 0.430 |
Why?
|
| Genes, Recessive | 6 | 2021 | 184 | 0.430 |
Why?
|
| Skin Neoplasms | 1 | 2020 | 857 | 0.400 |
Why?
|
| Epidermis | 3 | 2022 | 62 | 0.390 |
Why?
|
| Eczema | 2 | 2022 | 29 | 0.390 |
Why?
|
| DNA Mutational Analysis | 6 | 2019 | 810 | 0.380 |
Why?
|
| Loss of Function Mutation | 2 | 2025 | 150 | 0.370 |
Why?
|
| RNA Splicing | 2 | 2023 | 229 | 0.350 |
Why?
|
| Papillomaviridae | 5 | 2022 | 145 | 0.330 |
Why?
|
| Cohort Studies | 7 | 2024 | 4819 | 0.320 |
Why?
|
| Cutis Laxa | 2 | 2020 | 11 | 0.310 |
Why?
|
| Lipase | 3 | 2019 | 94 | 0.310 |
Why?
|
| 1-Acylglycerol-3-Phosphate O-Acyltransferase | 2 | 2019 | 2 | 0.310 |
Why?
|
| Dyslipidemias | 2 | 2024 | 235 | 0.300 |
Why?
|
| Male | 34 | 2025 | 61429 | 0.300 |
Why?
|
| Serine Endopeptidases | 2 | 2020 | 182 | 0.290 |
Why?
|
| Female | 31 | 2025 | 66669 | 0.290 |
Why?
|
| Blister | 2 | 2018 | 22 | 0.290 |
Why?
|
| Calcium-Binding Proteins | 2 | 2018 | 324 | 0.270 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2019 | 2654 | 0.260 |
Why?
|
| Child | 17 | 2025 | 24609 | 0.250 |
Why?
|
| Multidrug Resistance-Associated Proteins | 3 | 2022 | 22 | 0.250 |
Why?
|
| Adolescent | 13 | 2025 | 19412 | 0.250 |
Why?
|
| Genetic Association Studies | 6 | 2019 | 780 | 0.250 |
Why?
|
| Inheritance Patterns | 3 | 2021 | 127 | 0.240 |
Why?
|
| Phenotype | 12 | 2025 | 4266 | 0.240 |
Why?
|
| Vitamin E Deficiency | 1 | 2024 | 3 | 0.240 |
Why?
|
| Child, Preschool | 12 | 2025 | 14150 | 0.240 |
Why?
|
| GATA2 Transcription Factor | 1 | 2025 | 39 | 0.230 |
Why?
|
| Alleles | 5 | 2020 | 1614 | 0.230 |
Why?
|
| GTPase-Activating Proteins | 1 | 2025 | 87 | 0.230 |
Why?
|
| Vitamin E | 1 | 2024 | 69 | 0.230 |
Why?
|
| Heterocyclic Compounds | 1 | 2024 | 14 | 0.220 |
Why?
|
| Genomics | 4 | 2024 | 1520 | 0.220 |
Why?
|
| Oxidoreductases | 2 | 2021 | 92 | 0.210 |
Why?
|
| Incidental Findings | 1 | 2024 | 126 | 0.210 |
Why?
|
| Organometallic Compounds | 1 | 2024 | 111 | 0.210 |
Why?
|
| Haploinsufficiency | 1 | 2025 | 258 | 0.210 |
Why?
|
| Genetics, Medical | 1 | 2024 | 119 | 0.210 |
Why?
|
| Heterozygote | 3 | 2020 | 672 | 0.210 |
Why?
|
| DNA | 2 | 2019 | 1606 | 0.210 |
Why?
|
| Adult | 15 | 2025 | 29452 | 0.210 |
Why?
|
| Ataxia | 1 | 2024 | 169 | 0.210 |
Why?
|
| Ichthyosis Vulgaris | 1 | 2022 | 1 | 0.200 |
Why?
|
| Muscular Dystrophies, Limb-Girdle | 1 | 2022 | 24 | 0.200 |
Why?
|
| Vitamin D | 1 | 2024 | 166 | 0.200 |
Why?
|
| Inducible T-Cell Co-Stimulator Protein | 1 | 2022 | 8 | 0.200 |
Why?
|
| Muscular Dystrophies | 1 | 2022 | 53 | 0.190 |
Why?
|
| Keratinocytes | 2 | 2021 | 63 | 0.190 |
Why?
|
| Pyrin | 1 | 2021 | 3 | 0.190 |
Why?
|
| Familial Mediterranean Fever | 1 | 2021 | 4 | 0.190 |
Why?
|
| Tetraspanin 24 | 2 | 2021 | 2 | 0.190 |
Why?
|
| Homeodomain Proteins | 1 | 2025 | 556 | 0.190 |
Why?
|
| Connective Tissue | 1 | 2021 | 24 | 0.190 |
Why?
|
| Dermatitis | 1 | 2021 | 26 | 0.190 |
Why?
|
| T-Lymphocytes | 2 | 2021 | 1716 | 0.190 |
Why?
|
| Integrin alpha3 | 1 | 2021 | 2 | 0.180 |
Why?
|
| Vascular Calcification | 1 | 2022 | 56 | 0.180 |
Why?
|
| Leukocyte Disorders | 2 | 2020 | 2 | 0.180 |
Why?
|
| Claudin-1 | 2 | 2020 | 20 | 0.180 |
Why?
|
| CD28 Antigens | 1 | 2021 | 81 | 0.180 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 1 | 2020 | 18 | 0.180 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2021 | 214 | 0.180 |
Why?
|
| Alopecia | 2 | 2020 | 39 | 0.170 |
Why?
|
| Mycoses | 1 | 2021 | 117 | 0.170 |
Why?
|
| Cholangitis, Sclerosing | 2 | 2020 | 59 | 0.170 |
Why?
|
| Hereditary Autoinflammatory Diseases | 1 | 2020 | 10 | 0.170 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2025 | 501 | 0.160 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2020 | 54 | 0.160 |
Why?
|
| Chromosome Mapping | 2 | 2019 | 1086 | 0.160 |
Why?
|
| Neutropenia | 1 | 2021 | 196 | 0.160 |
Why?
|
| Genes, Modifier | 1 | 2019 | 12 | 0.160 |
Why?
|
| Carrier Proteins | 1 | 2024 | 1027 | 0.160 |
Why?
|
| Keratoderma, Palmoplantar | 1 | 2018 | 5 | 0.160 |
Why?
|
| Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase | 1 | 2018 | 7 | 0.150 |
Why?
|
| Neoplasms | 2 | 2023 | 2790 | 0.150 |
Why?
|
| Chromosome Fragility | 1 | 2018 | 13 | 0.150 |
Why?
|
| DNA, Recombinant | 1 | 2018 | 105 | 0.150 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2022 | 561 | 0.150 |
Why?
|
| Non-Fibrillar Collagens | 1 | 2018 | 2 | 0.150 |
Why?
|
| Betapapillomavirus | 1 | 2018 | 1 | 0.150 |
Why?
|
| Epidermolysis Bullosa, Junctional | 1 | 2018 | 3 | 0.150 |
Why?
|
| Phenylalanine Hydroxylase | 1 | 2018 | 12 | 0.150 |
Why?
|
| Gastrointestinal Diseases | 1 | 2022 | 339 | 0.150 |
Why?
|
| Down-Regulation | 2 | 2018 | 692 | 0.150 |
Why?
|
| Connexins | 1 | 2018 | 60 | 0.150 |
Why?
|
| Phenylketonurias | 1 | 2018 | 13 | 0.150 |
Why?
|
| DNA Copy Number Variations | 1 | 2023 | 963 | 0.150 |
Why?
|
| Receptors, Peptide | 1 | 2018 | 50 | 0.150 |
Why?
|
| Peru | 1 | 2018 | 47 | 0.150 |
Why?
|
| Keratosis | 1 | 2018 | 17 | 0.150 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2019 | 214 | 0.150 |
Why?
|
| Photosensitivity Disorders | 1 | 2017 | 10 | 0.140 |
Why?
|
| Autoantigens | 1 | 2018 | 109 | 0.140 |
Why?
|
| Sphingosine N-Acyltransferase | 1 | 2017 | 1 | 0.140 |
Why?
|
| Syndrome | 4 | 2023 | 1119 | 0.140 |
Why?
|
| Quantitative Trait Loci | 1 | 2019 | 287 | 0.140 |
Why?
|
| Phosphoric Diester Hydrolases | 3 | 2022 | 65 | 0.140 |
Why?
|
| Genetic Variation | 1 | 2024 | 1505 | 0.140 |
Why?
|
| Periodontal Diseases | 1 | 2017 | 25 | 0.140 |
Why?
|
| Mexico | 1 | 2018 | 181 | 0.140 |
Why?
|
| Frameshift Mutation | 1 | 2018 | 181 | 0.140 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 292 | 0.140 |
Why?
|
| Microsatellite Repeats | 1 | 2018 | 222 | 0.140 |
Why?
|
| Multiprotein Complexes | 1 | 2018 | 210 | 0.140 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2018 | 144 | 0.140 |
Why?
|
| Pyrroline Carboxylate Reductases | 1 | 2016 | 6 | 0.130 |
Why?
|
| Point Mutation | 1 | 2018 | 350 | 0.130 |
Why?
|
| Gene Expression Profiling | 2 | 2021 | 1757 | 0.130 |
Why?
|
| Keratin-14 | 1 | 2016 | 9 | 0.130 |
Why?
|
| Keratin-5 | 1 | 2016 | 9 | 0.130 |
Why?
|
| Hodgkin Disease | 1 | 2019 | 290 | 0.130 |
Why?
|
| Infant | 5 | 2024 | 12610 | 0.130 |
Why?
|
| Stroke | 1 | 2024 | 982 | 0.130 |
Why?
|
| Genome, Human | 2 | 2021 | 1293 | 0.120 |
Why?
|
| Immunity, Innate | 1 | 2018 | 372 | 0.120 |
Why?
|
| Computational Biology | 1 | 2020 | 819 | 0.120 |
Why?
|
| Genome-Wide Association Study | 2 | 2024 | 1694 | 0.120 |
Why?
|
| Hospitalization | 1 | 2023 | 1783 | 0.120 |
Why?
|
| Intellectual Disability | 2 | 2025 | 1054 | 0.110 |
Why?
|
| Brain Neoplasms | 1 | 2023 | 1316 | 0.110 |
Why?
|
| Guanine Nucleotide Exchange Factors | 2 | 2025 | 91 | 0.110 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2019 | 403 | 0.110 |
Why?
|
| Kidney Diseases | 1 | 2017 | 483 | 0.100 |
Why?
|
| Genotype | 4 | 2019 | 2569 | 0.100 |
Why?
|
| Basement Membrane | 2 | 2022 | 48 | 0.090 |
Why?
|
| Cardiovascular Diseases | 1 | 2024 | 1958 | 0.090 |
Why?
|
| Siblings | 2 | 2020 | 186 | 0.080 |
Why?
|
| Young Adult | 5 | 2020 | 9054 | 0.070 |
Why?
|
| Cell Adhesion | 2 | 2020 | 345 | 0.070 |
Why?
|
| RNA Splice Sites | 2 | 2019 | 91 | 0.070 |
Why?
|
| Sequence Analysis, DNA | 3 | 2018 | 1762 | 0.070 |
Why?
|
| Sequence Analysis, RNA | 2 | 2021 | 372 | 0.070 |
Why?
|
| Gene Frequency | 2 | 2019 | 728 | 0.070 |
Why?
|
| Comorbidity | 2 | 2023 | 1526 | 0.060 |
Why?
|
| Cell Movement | 2 | 2021 | 850 | 0.060 |
Why?
|
| Base Sequence | 2 | 2021 | 3107 | 0.060 |
Why?
|
| Severity of Illness Index | 3 | 2018 | 2905 | 0.060 |
Why?
|
| Founder Effect | 1 | 2024 | 32 | 0.060 |
Why?
|
| Immunohistochemistry | 2 | 2018 | 1701 | 0.060 |
Why?
|
| Zebrafish Proteins | 1 | 2025 | 116 | 0.060 |
Why?
|
| Prognosis | 3 | 2018 | 4683 | 0.050 |
Why?
|
| Likelihood Functions | 1 | 2024 | 114 | 0.050 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2024 | 85 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 2021 | 2813 | 0.050 |
Why?
|
| Animals | 5 | 2025 | 34205 | 0.050 |
Why?
|
| Plectin | 1 | 2022 | 3 | 0.050 |
Why?
|
| Retinoids | 1 | 2022 | 34 | 0.050 |
Why?
|
| Zebrafish | 1 | 2025 | 380 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2024 | 284 | 0.050 |
Why?
|
| Introns | 1 | 2023 | 300 | 0.050 |
Why?
|
| Pyrophosphatases | 1 | 2022 | 21 | 0.050 |
Why?
|
| Cholesterol, HDL | 1 | 2024 | 355 | 0.050 |
Why?
|
| Chromosome Deletion | 1 | 2025 | 653 | 0.050 |
Why?
|
| Computer Simulation | 1 | 2024 | 650 | 0.050 |
Why?
|
| Papilloma | 1 | 2021 | 23 | 0.050 |
Why?
|
| Protein Sorting Signals | 1 | 2021 | 39 | 0.050 |
Why?
|
| Jurkat Cells | 1 | 2021 | 92 | 0.050 |
Why?
|
| Triglycerides | 1 | 2024 | 571 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 4415 | 0.050 |
Why?
|
| Water Loss, Insensible | 1 | 2021 | 3 | 0.050 |
Why?
|
| Skin Abnormalities | 1 | 2021 | 33 | 0.040 |
Why?
|
| gamma Catenin | 1 | 2020 | 1 | 0.040 |
Why?
|
| Endopeptidases | 1 | 2021 | 116 | 0.040 |
Why?
|
| Immunity, Humoral | 1 | 2021 | 71 | 0.040 |
Why?
|
| Exons | 1 | 2023 | 802 | 0.040 |
Why?
|
| Serine Peptidase Inhibitor Kazal-Type 5 | 1 | 2020 | 3 | 0.040 |
Why?
|
| Oncogenes | 1 | 2021 | 176 | 0.040 |
Why?
|
| Kallikreins | 1 | 2020 | 27 | 0.040 |
Why?
|
| Ichthyosiform Erythroderma, Congenital | 1 | 2020 | 4 | 0.040 |
Why?
|
| Lipid Metabolism, Inborn Errors | 1 | 2020 | 20 | 0.040 |
Why?
|
| Skin Physiological Phenomena | 1 | 2020 | 20 | 0.040 |
Why?
|
| DNA, Viral | 1 | 2021 | 478 | 0.040 |
Why?
|
| Mucositis | 1 | 2020 | 19 | 0.040 |
Why?
|
| Immunologic Memory | 1 | 2021 | 190 | 0.040 |
Why?
|
| Fatty Acid Transport Proteins | 1 | 2019 | 11 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2021 | 368 | 0.040 |
Why?
|
| England | 1 | 2019 | 60 | 0.040 |
Why?
|
| Middle Aged | 4 | 2021 | 26670 | 0.040 |
Why?
|
| Acitretin | 1 | 2019 | 1 | 0.040 |
Why?
|
| Biological Transport | 1 | 2020 | 352 | 0.040 |
Why?
|
| Keratolytic Agents | 1 | 2019 | 4 | 0.040 |
Why?
|
| Muscular Diseases | 1 | 2020 | 101 | 0.040 |
Why?
|
| Cell Communication | 1 | 2020 | 167 | 0.040 |
Why?
|
| Connexin 26 | 1 | 2018 | 14 | 0.040 |
Why?
|
| Exanthema | 1 | 2020 | 71 | 0.040 |
Why?
|
| Sodium | 1 | 2020 | 296 | 0.040 |
Why?
|
| Hearing Loss, Bilateral | 1 | 2018 | 17 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2021 | 737 | 0.040 |
Why?
|
| Drug Therapy | 1 | 2019 | 87 | 0.040 |
Why?
|
| Xenopus | 1 | 2018 | 112 | 0.040 |
Why?
|
| Metalloendopeptidases | 1 | 2018 | 101 | 0.040 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2019 | 190 | 0.040 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2021 | 471 | 0.040 |
Why?
|
| Oncogene Proteins, Viral | 1 | 2018 | 58 | 0.040 |
Why?
|
| Human papillomavirus 16 | 1 | 2018 | 50 | 0.040 |
Why?
|
| Biopsy, Needle | 1 | 2018 | 228 | 0.040 |
Why?
|
| Codon, Nonsense | 1 | 2018 | 131 | 0.040 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2019 | 223 | 0.040 |
Why?
|
| Sampling Studies | 1 | 2017 | 75 | 0.040 |
Why?
|
| Genetics, Population | 1 | 2018 | 187 | 0.040 |
Why?
|
| Fever | 1 | 2020 | 297 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2021 | 2709 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2021 | 680 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2018 | 508 | 0.030 |
Why?
|
| Oocytes | 1 | 2018 | 298 | 0.030 |
Why?
|
| Connective Tissue Diseases | 1 | 2016 | 30 | 0.030 |
Why?
|
| Geography | 1 | 2016 | 116 | 0.030 |
Why?
|
| Epitope Mapping | 1 | 2016 | 80 | 0.030 |
Why?
|
| Gene Expression | 1 | 2021 | 1550 | 0.030 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2019 | 292 | 0.030 |
Why?
|
| Family Health | 1 | 2016 | 256 | 0.030 |
Why?
|
| Family | 1 | 2019 | 562 | 0.030 |
Why?
|
| Calcium | 1 | 2020 | 1099 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2018 | 356 | 0.030 |
Why?
|
| Haplotypes | 1 | 2016 | 520 | 0.030 |
Why?
|
| Mice | 2 | 2021 | 17711 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 2181 | 0.030 |
Why?
|
| Biopsy | 1 | 2016 | 1242 | 0.020 |
Why?
|
| Prevalence | 1 | 2019 | 2458 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2019 | 3753 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 2093 | 0.020 |
Why?
|
| Aged | 2 | 2019 | 19653 | 0.020 |
Why?
|
| Risk Factors | 1 | 2024 | 10278 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2018 | 3422 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 4405 | 0.020 |
Why?
|
| Pregnancy | 1 | 2021 | 7215 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 6535 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2019 | 8272 | 0.020 |
Why?
|